Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Dec;45(244):735-45.
doi: 10.1136/adc.45.244.735.

Treatment of primary hyperoxaluria

Treatment of primary hyperoxaluria

C E Dent et al. Arch Dis Child. 1970 Dec.

Abstract

Nine patients with primary hyperoxaluria have been followed regularly for 1 to 11 years, and their treatment and progress are discussed in relation to the known natural history of the disease. 6 of them probably have the usual form of primary hyperoxaluria associated with increased glycollic acid excretion, while 3 who are sibs have the recently described variant associated with L-glyceric aciduria and normal glycollic acid excretion.

All 9 patients have been on regimens designed to increase the urinary solubility of calcium oxalate, with or without the simultaneous lowering of urinary calcium and raising of urinary phosphate excretions. 8 patients have been treated for 1½-7½ years (average duration 4 years) with oral magnesium hydroxide, and 2 patients have been treated with sodium phosphate. One of the latter was changed after 3½ years to magnesium hydroxide and the other has been on sodium phosphate combined with a low calcium diet and cellulose phosphate continuously for 5½ years. 2, not at first diagnosed as hyperoxalurics, were first given sodium bicarbonate for their presumably secondary renal tubular acidosis.

The over-all progress of the whole group is felt to have been better than could be expected from the known natural history of primary hyperoxaluria. They average 4¼ years on treatment during 5 years of our observation and all remain clinically well after an average of 9½ years since the onset of their first symptoms. Results warrant the recommendation that, until reliable means are available to decrease oxalate over-production, affected patients should be treated continuously with magnesium hydroxide. A more final opinion must await many more years of follow-up.

The failure of several attempts to lower urinary oxalate excretion in these patients is also reported.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Invest Urol. 1966 Sep;4(2):133-42 - PubMed
    1. N Engl J Med. 1967 Jan 26;276(4):207-10 - PubMed
    1. Am J Clin Nutr. 1967 May;20(5):393-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1967 Apr;57(4):1123-9 - PubMed
    1. Mod Treat. 1967 May;4(3):522-30 - PubMed

MeSH terms

LinkOut - more resources